Cardlytics Inc reports results for the quarter ended in January 1 - Earnings Summary

• Cardlytics Inc CDLX.OQ reported a quarterly adjusted loss of 15 cents​​ per share for the quarter ended January 1, lower than the same quarter last year, when the company reported EPS of 1 cents. The mean expectation of five analysts for the quarter was for a loss of 24 cents per share. Wall Street expected results to range from -33 cents to -14 cents per share.

• Revenue fell 15.1% to $67.06 million from a year ago; analysts expected $57.79 million.

• Cardlytics Inc's reported EPS for the quarter was a loss of $2.90​.

• The company reported a quarterly loss of $145.18 million.

• Cardlytics Inc shares had risen by 46.6% this quarter and lost 49.1% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 1.7% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy," 5 "hold" and 1 "sell" or "strong sell."

• The average consensus recommendation for the software peer group is also "hold"

Wall Street's median 12-month price target for Cardlytics Inc is $4.00

This summary was machine generated from LSEG data November 7 at 04:08 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)